Macular degeneration is the gradual loss of central vision in the eye.
Macular degeneration, also known as age related macular degeneration (AMD), is the gradual loss of central vision in the eye. The risk of developing AMD increases after the age of 55, and it is a leading cause of vision loss in older adults. Once developed, AMD can be treated, and it may be slowed with early detection and prevention, so it is important to keep an eye on your vision with regular checkups.
There are two types of AMD — wet and dry.
Dry AMD is the most common form, and affects more than 75% of people with AMD. In this form of macular degeneration, the macula (the part of the retina that affects your ability to see fine details) gets thinner, and yellowish deposits of protein grow in the eye, causing a slow loss of central vision. Dry AMD has the potential to turn into wet AMD.
Wet AMD is a more serious and advanced form of AMD, and accounts for less than 25% of cases. It can result in full loss of central vision, and happens when abnormal blood vessels form under the retina and can leak fluid and blood, damaging the macula. There are many risk factors that can affect your likelihood to get AMD in your lifetime, but the disease is most common in caucasian people who have a family history of AMD. Other factors to be aware of include:
- High blood pressure
There are many promising paths being paved in the treatment of AMD, and Sterling is proud to provide expert care in this area. In addition to assisting patients with tailored treatment options, we participate in advanced clinical trials to further pave the way for restored vision for our patients.
Learn more about the treatment options and leading care available to you on our website: https://www.sterlingvision.com/clinical-trials/